Update in reperfusion therapy for acute myocardial infarction
Download
1 / 49

Educational Process - PowerPoint PPT Presentation


  • 353 Views
  • Updated On :

Eddy Lang MD Attending Staff Emergency Department Jewish General Hospital. Update in reperfusion therapy for acute myocardial infarction. Educational Process Objectives. Use a problem-solving approach to address two controversial topics in MI reperfusion

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Educational Process ' - Pat_Xavi


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Update in reperfusion therapy for acute myocardial infarction l.jpg

Eddy Lang MD

Attending Staff

Emergency Department

Jewish General Hospital

Update in reperfusion therapy for acute myocardial infarction


Educational process objectives l.jpg
Educational Process Objectives

  • Use a problem-solving approach to address two controversial topics in MI reperfusion

  • Review databases of research evidence

  • Introduce the concept of the study synopsis


Clinical scenario l.jpg
Clinical Scenario

  • 52 year old male with chest pain x 2 hrs.

  • No history of CAD, risk factors ++

  • Severe central C/P with radiation and diaphoresis and SOB

  • No known bleeding

  • No head trauma


Clinical scenario4 l.jpg
Clinical Scenario

  • Pale, diaphoretic

  • BP 140/70 Pulse 115 RR 24

  • Chest: clear

  • CVS: Normal HS; Ø JVD; Ø murmers

  • Abdo: soft

  • CNS: normal


Clinical setting l.jpg
Clinical Setting

  • 4th year EM resident moonlighting at the Lakeshore

  • Girlfriend/boyfriend working ED at JGH

  • No formal transfer arrangement

  • Arrange primary PTCA and transfer?

    (ignore the politics)


Clinical question l.jpg
Clinical Question

In patients with acute myocardial infarction who are candidates for reperfusion therapy but present to a center that doesn’t offer PCA does transport to a center with cath lab capabilities within a 3-hour window compared to early thrombolysis on-site reduce mortality?


Search strategy l.jpg
Search Strategy

  • Question type

  • Resource: where would you look?

    • systematic review

    • shortcut reviews

    • primary RCTs

    • meta-search engines

    • cutting edge studies



Shortcut review l.jpg
Shortcut Review

10 trials

2 600 pts.











Clinical scenario43 l.jpg
Clinical Scenario

  • 52 year old male with chest pain x 2 hrs.

  • No history of CAD, risk factors ++

  • Severe central C/P with radiation and diaphoresis and SOB

  • No known bleeding

  • No head trauma


Clinical setting44 l.jpg
Clinical Setting

  • 4th year resident moonlighting on a rural rotation

  • Extremely well-stocked ED pharmacy

  • Ø IIb/IIIa inhibitors

  • PCI unavailable

  • In addition to ASA what anti-thrombin therapy should you give?

  • UFH (most familiar)? LMWH? Does it matter?


Clinical question45 l.jpg
Clinical Question

In patients with acute myocardial infarction who are receiving thrombolytic therapy and ASA does adjuvant antithrombin therapy with LMWH in comparison with UFH reduce adverse cardiac events during the following 30 days without an unacceptable increase in bleeding?


Slide46 l.jpg

Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction

ASSENT 3

The ASSENT-3 Investigators

Lancet 2001;358:605–13


Breakout tasks l.jpg
Breakout tasks

  • Develop a study synopsis

    1. Maximum 5 sentences

  • Appraise methodology

    2. Prognosis before the start of the study

    3. Prognosis after the start of the study

  • Define the key issues in applicability

    4. Why not use it


Slide48 l.jpg

Aside from the experimental intervention,

were groups treated equally?


Conclusions l.jpg
Conclusions

  • PCA:

  • Even with 90 min additional delay PCA superior to lysis

  • Evidence behooves the interventionist to come in at 2:00am

  • Referral centers are coming

  • Adjuvant anti-thrombotic therapy:

  • Enoxaparin superior to UFH


ad